Showing results (1251-1260 of 4,703) with videos related to

Sort By:
Pageof 471
Seminars in Oncology|June 1, 2002
Beyond immunochemotherapy: combinations of rituximab with cytokines interferon-alpha2a and granulocyte colony stimulating factor [corrected]Eva Kimby
Seminars in Oncology|June 14, 2002
c-erbB-2 in breast cancer: development of a clinically useful markerDaniel F Hayes, Ann D Thor
Seminars in Oncology|June 14, 2002
Clinical translation of gene expression profiling in lymphomas and leukemiasAndreas Rosenwald, Louis M Staudt
Seminars in Oncology|June 14, 2002
Regulatory issues in tumor marker developmentSteven Gutman
Seminars in Oncology|May 23, 2002
Folate status and the safety profile of antifolatesHilary Calvert
Seminars in Oncology|May 23, 2002
Pemetrexed in patients with gastrointestinal carcinomaAimery de Gramont, Hedy L Kindler
Seminars in Oncology|January 5, 2002
Inhibitors of HER2/neu (erbB-2) signal transductionC L Arteaga, W Chinratanalab, M B Carter
Seminars in Oncology|February 11, 2003
Early results from a phase I/II radiation dose-escalation study with concurrent amifostine and infusional 5-fluorouracil chemotherapy for preoperative treatment of unresectable or locally recurrent rectal carcinomaRobert Myerson, Imran Zobeiri, Elisa Birnbaum, et al.
Seminars in Oncology|February 11, 2003
A phase III randomized evaluation of amifostine in stage IIIA/IIIB non-small cell lung cancer patients receiving concurrent carboplatin, paclitaxel, and radiation therapy followed by gemcitabine and cisplatin intensification: preliminary findingsNeil Senzer
Seminars in Oncology|February 11, 2003
Tools for optimal tissue sparing in concomitant chemoradiation of advanced head and neck cancer: subcutaneous amifostine and computed tomography-based target delineationMarijel Braaksma, Peter Levendag
Pageof 471